Caissa Capital Management ltd. - May 12, 2023 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
10%+ Owner
Signature
Cambyz Golestaneh, Title: Director
Stock symbol
AVTX
Transactions as of
May 12, 2023
Transactions value $
$11,007
Form type
4
Date filed
5/16/2023, 05:23 PM
Previous filing
May 8, 2023
Next filing
May 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTX Common stock Purchase $5.6K +2.29K +0.17% $2.45 1.34M May 12, 2023 See Footnote (1) F1
transaction AVTX Common stock Purchase $4.37K +1.72K +0.13% $2.55 1.35M May 15, 2023 See Footnote (1) F1, F2
transaction AVTX Common stock Purchase $1.04K +379 +0.03% $2.75* 1.35M May 16, 2023 See Footnote (1) F1
holding AVTX Common stock 182K May 12, 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.45 to $2.79, inclusive.
F3 These shares are directly owned by Mr. Golestaneh in his personal capacity.